HNB
TVTX icon

Huntington National Bank’s Travere Therapeutics TVTX Stock Holding History

Huntington National Bank’s Portfolio TVTX Stock Details TVTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$23K Sell
774
-11
-1% -$329 ﹤0.01% 1601
2025
Q4 		$30K Sell
785
-445
-36% -$14.5K ﹤0.01% 1441
2025
Q3 		$29.4K Buy
1,230
+174
+16% +$3.27K ﹤0.01% 1466
2025
Q2 		$15.6K Sell
1,056
-23
-2% -$381 ﹤0.01% 1649
2025
Q1 		$19.3K Buy
1,079
+10
+0.9% +$203 ﹤0.01% 1527
2024
Q4 		$18.6K Sell
1,069
-299
-22% -$5.29K ﹤0.01% 1566
2024
Q3 		$19.1K Buy
1,368
+383
+39% +$3.99K ﹤0.01% 1526
2024
Q2 		$8.1K Sell
985
-28
-3% -$189 ﹤0.01% 1758
2024
Q1 		$7.81K Sell
1,013
-39
-4% -$329 ﹤0.01% 1766
2023
Q4 		$9.46K Sell
1,052
-10
-0.9% -$73 ﹤0.01% 1672
2023
Q3 		$9.49K Sell
1,062
-881
-45% -$12.4K ﹤0.01% 1578
2023
Q2 		$29.8K Buy
1,943
+712
+58% +$13K ﹤0.01% 1235
2023
Q1 		$27.7K Buy
1,231
+215
+21% +$4.57K ﹤0.01% 1203
2022
Q4 		$21.4K Buy
1,016
+60
+6% +$1.27K ﹤0.01% 1261
2022
Q3 		$24K Hold
956
– – ﹤0.01% 1228
2022
Q2 		$23K Buy
956
+551
+136% +$13.9K ﹤0.01% 1284
2022
Q1 		$10K Sell
405
-2
-0.5% -$53 ﹤0.01% 1612
2021
Q4 		$13K Buy
407
+89
+28% +$2.51K ﹤0.01% 1520
2021
Q3 		$8K Buy
+318
New +$5.84K ﹤0.01% 1503

Other funds holding TVTX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Huntington National Bank's TVTX Position: Q1 2026 in Review

Huntington National Bank reduced its Travere Therapeutics (TVTX) stake by 1.4% in Q1 2026, selling an estimated $329 and leaving 774 shares worth $23K. The position accounts for ﹤0.01% of the portfolio, ranked #1601.

Huntington National Bank first reported a position in TVTX in Q3 2021 and has held it in 19 quarters since. The position peaked at $30K in Q4 2025. 260 funds tracked by Wall St. Rank hold TVTX as of Q1 2026.

  • Huntington National Bank held 774 shares of Travere Therapeutics worth $23K as of Q1 2026.
  • Huntington National Bank sold 11 Travere Therapeutics shares in Q1 2026, an estimated $329.
  • Travere Therapeutics made up ﹤0.01% of Huntington National Bank's portfolio in Q1 2026, its #1601 holding.
  • Huntington National Bank first reported a position in Travere Therapeutics in Q3 2021 and has held it in 19 quarters since.
  • Huntington National Bank's Travere Therapeutics position peaked at $30K in Q4 2025.
  • 260 funds tracked by Wall St. Rank held Travere Therapeutics as of Q1 2026.

Based on Huntington National Bank's 13F filing for Q1 2026, filed 15 May 2026.